Cargando…
Organoid models combined with genome engineering and epigenome studies to define SOX2 function evolution in esophageal squamous cell carcinoma
Autor principal: | Diao, Fei‐Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520791/ https://www.ncbi.nlm.nih.gov/pubmed/34459113 http://dx.doi.org/10.1111/1759-7714.14118 |
Ejemplares similares
-
Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma
por: Min, Qingjie, et al.
Publicado: (2021) -
Defining conversion therapy for esophageal squamous cell carcinoma
por: Matsuda, Satoru, et al.
Publicado: (2022) -
Novel mechanism of immune evasion mediated by tumor‐associated macrophages in esophageal squamous cell carcinoma
por: Diao, Fei‐Yu
Publicado: (2020) -
Genomic and Epigenomic Characterization of Tumor Organoid Models
por: Nam, Chehyun, et al.
Publicado: (2022) -
Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma
por: Lu, Jun-Tao, et al.
Publicado: (2023)